Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis | Zendy

Donn Colby | Zendy; Eugène Kroon | Zendy; Carlo Sacdalan | Zendy; Monica Gandhi | Zendy; Robert M. Grant | Zendy; Praphan Phanuphak | Zendy; Jintanat Ananworanich | Zendy; Merlin L. Robb | Zendy; Nittaya Phanuphak | Zendy

Open Access

Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis

Author(s) -

Donn Colby,

Eugène Kroon,

Carlo Sacdalan,

Monica Gandhi,

Robert M. Grant,

Praphan Phanuphak,

Jintanat Ananworanich,

Merlin L. Robb,

Nittaya Phanuphak

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy321

Subject(s) - medicine , emtricitabine , seroconversion , virology , human immunodeficiency virus (hiv) , multiple drug resistance , immunology , drug resistance , viral load , microbiology and biotechnology , antiretroviral therapy , biology

We report a case indicating that acquisition of multidrug-resistant human immunodeficiency (HIV) virus type 1 during preexposure prophylaxis with combination tenofovir disoproxil fumarate and emtricitabine or evolution of resistance after HIV seroconversion remains a risk.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research